No Data
Boston Scientific's Upside With Cardiology Devices Drives Momentum
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
GE HealthCare (GEHC), Medis Medical Partner to Aid CAD Therapy
Decoding 18 Analyst Evaluations For Boston Scientific
Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Boston Scientific (NYSE:BSX) in the last three months.The following table provides a quick over
Boston Scientific Is Maintained at Buy by Mizuho
Boston Scientific Is Maintained at Buy by Mizuho
Boston Scientific Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 22.47% Mizuho $85 → $90 Maintains Buy 04/26/2024 6.14% Barclays $70 → $78 Maintains Overweight
104575863 : hai
103625245 : hai guys
74049856 : someone please close my account